Open AccessFeatures Of The Pathogenesis And Correction Of Anemia Induced By Antiviral Therapy For Hepatitis C
Author(s) -
Ismatova Mekhriniso Nasritdinovna
Publication year - 2021
Publication title -
the american journal of medical sciences and pharmaceutical research
Language(s) - English
Resource type - Journals
ISSN - 2689-1026
DOI - 10.37547/tajmspr/volume03issue04-30
Subject(s) - medicine , cirrhosis , hepatitis c virus , pathogenesis , incidence (geometry) , anemia , antiviral therapy , adverse effect , hepatitis c , disease , liver disease , gastroenterology , virus , immunology , chronic hepatitis , physics , optics
HCV infection remains one of the leading problems in the diagnosis and treatment of chronic liver disease, given the scale of hepatitis C virus infection worldwide, the significant number of unexamined but at-risk patients, and the incidence of cirrhosis and liver cancer. Anemia is the most common hematological adverse event, which in turn significantly reduces the quality of life of patients during antiviral therapy, their adherence to treatment, and increases the risk of developing cardiovascular, renal and cerebral disorders.